Being part of the advances in the surgical treatment of colorectal cancer

Being part of the advances in the surgical treatment of colorectal cancer

Euroclinic and its experienced and well-qualified surgeons will participate in two European Programs which aim to promote the benefits derived from Minimally Invasive Robotic Surgery in treating colon and rectal conditions. This will be the only delegate from the Greek private healthcare sector, joining 40 top European and Korean centers. By analyzing and comparing data for over 2500 patients who will undergo open, laparoscopic and robotic colorectal cancer surgery, an effort is being made to promote the benefits derived from minimally invasive techniques and establish them as a method of choice for treating such conditions.

Although international and European Guidelines recommend treating colorectal cancer with minimally invasive techniques, robotics is currently the method of choice only in the USA and selected large centers across Western Europe. This is mainly due to a lack of surgical teams sufficiently experienced and specialized in this method. As a result, more than 50% of patients in less developed countries undergo open surgery, which increases complications, such as postoperative pain, days of hospitalization and cases of permanent colostomies. Furthermore, there is now evidence that open surgery leads to worse oncologic results, which means that patients have higher chances of losing the battle with this type of cancer.

Colorectal cancer is the third most common cancer in men and the second most common cancer in women. It is estimated that over 1.8 million new cases occurred across the world in 2018, while over 1/3 of those patients will lose the battle with this disease.

Mr. Antonis Vouklaris, CEO of the Euroclinic Group, stated, “Through its specialists and medical technology, Euroclinic proves its leading role in shaping cutting-edge developments in medicine that aim to treat serious diseases and provide quality medical services to patients.”

Ms. Thaleia Petropoulou MD, PhD, FRCS, Surgeon, specializing in Minimally Invasive Robotic Surgery of the Lower Digestive Tract, stated, “Promoting and establishing robotic surgery as the method of choice for colorectal cancer procedures, especially for high-risk patients, will constitute a key step in treating this type of cancer, by offering faster recovery, fewer complications and, potentially, better oncologic results and quality of life for our patients.”